Physician profile
Sneha Pai
NPI 1336484757
$2,246.69
in general payments reported to CMS, 2019-2025
20 companies · $42.83 in 2025
The $42.83 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $420 · 2021: $123 · 2022: $121 · 2023: $41.99 · 2024: $69.02 · 2025: $42.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $416.44 | 2019-2022 | |
| Genentech USA, INC. | $336.67 | 2019-2020 | |
| Abbvie INC. | $304.13 | 2019-2020 | |
| Glaxosmithkline, LLC. | $283.82 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $184.05 | 2021-2025 | |
| Janssen Biotech, INC. | $156.30 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.86 | 2020-2021 | |
| Pfizer INC. | $86.54 | 2019-2020 | |
| Lilly USA, LLC | $54.48 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $54.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $52.13 | 2019-2020 | |
| Genzyme Corporation | $43.56 | 2019 | |
| Sobi, INC | $42.82 | 2019 | |
| Hikma Pharmaceuticals USA | $28.61 | 2019 | |
| Ucb, INC. | $27.52 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $15.91 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $14.22 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.95 | 2019 | |
| Medexus Pharma, INC. | $12.56 | 2019 | |
| Horizon Therapeutics Plc | $11.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sneha Pai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.